Hemolytic-uremic syndrome natural history, complications and prognosis
Hemolytic-uremic syndrome Microchapters |
Differentiating Hemolytic-uremic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hemolytic-uremic syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hemolytic-uremic syndrome natural history, complications and prognosis |
FDA on Hemolytic-uremic syndrome natural history, complications and prognosis |
CDC on Hemolytic-uremic syndrome natural history, complications and prognosis |
Hemolytic-uremic syndrome natural history, complications and prognosis in the news |
Blogs on Hemolytic-uremic syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of HUS usually develop after eating of contaminated food in the first diarrhea is watery and become to bloody later. and start with symptoms such as abdominal pain, nausea and vomiting accompany diarrhea , Fever is observed less commonly.[1]
- The symptoms of HUS typically develop 5–15% of the cases. [2]
- If left untreated 15% of patients with HUS may progress to develop rectal prolapse, acute renal failure , colonic gangrene , and mortality .[3]
Complications
- Common complications of HUS include:
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Nur Canpolat (2015). "Hemolytic uremic syndrome". Turk pediatri arsivi. 50 (2): 73–82. doi:10.5152/tpa.2015.2297. PMID 26265890. Unknown parameter
|month=
ignored (help) - ↑ Nur Canpolat (2015). "Hemolytic uremic syndrome". Turk pediatri arsivi. 50 (2): 73–82. doi:10.5152/tpa.2015.2297. PMID 26265890. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Karpman, Diana; Loos, Sebastian; Tati, Ramesh; Arvidsson, Ida (2017). "Haemolytic uraemic syndrome". Journal of Internal Medicine. 281 (2): 123–148. doi:10.1111/joim.12546. ISSN 0954-6820.
- ↑ Mele, Caterina; Remuzzi, Giuseppe; Noris, Marina (2014). "Hemolytic uremic syndrome". Seminars in Immunopathology. 36 (4): 399–420. doi:10.1007/s00281-014-0416-x. ISSN 1863-2297.